Downregulation of β-arrestin 1 suppresses glioblastoma cell malignant progressionvisinhibition of Src signaling

    loading  Checking for direct PDF access through Ovid


Glioblastoma multiforme (GBM) is one of the most common brain malignancies worldwide and is typically associated with a dismal prognosis, yet the mechanisms underlying its aggressiveness remain unclear. Here, we revealed that β-arrestin 1 was overexpressed in GBM and contributed to poorer outcome. Knockdown of β-arrestin 1 suppressed the proliferation, invasiveness and glycolysis of GBM cells, and also enhanced temozolomide efficacy. Further, we discovered that knockdown of β-arrestin 1 decreased the activity of Src, and suppression of Src signaling was critically involved in β-arrestin 1 silencing-mediated suppression of GBM malignancies. Finally, we investigated the effect of β-arrestin 1 knockdown on the tumor growth and survival of xenograft models, and found that shβ-arrestin 1 apparently inhibited GBM growth in vivo and resulted in better survival of mice. Taken together, our findings suggest that knockdown of β-arrestin 1 can suppress GBM cell proliferation, invasion and glycolysis by inhibiting Src signaling. Thus, targeting β-arrestin 1 may be a potential therapeutic strategy for GBM treatment.HighlightsExpression of β-arrestin 1 was upregulated in GBM and contributed to poor outcome.Knockdown of β-arrestin 1 inhibited the proliferation and glycolysis of GBM cells.Knockdown of β-arrestin 1 decreased the activity of Src signaling and expressions of malignancy-related factors.Knockdown of β-arrestin 1 suppressed GBM growth in vivo.

    loading  Loading Related Articles